In BTK highly expressed primary neuroblastoma samples, BTK inhibitor acalabrutinib elicited remarkable effect on inhibition of neuroblastoma tumorigenesis (Pikatan et al., 2020). This evidence concerns the gene BTK and neuroblastoma.